Jim Hoffman: Targeting NETosis and Microclotting to Restore Immune and Hemostatic Balance
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, shared Ronald Li’s post on LinkedIn, adding:
“Very interesting and informative in vitro studies.
You may want to investigate this further with Resia Pretorius and the PolyBio team who are looking for better treatment of microclotting, post infection Illnesses, including Long COVID PASC.
Perhaps desulfated-heparin analogs could help better mitigate the development of severe life-threatening NETosis dysregulation and circulatory decline, if tried in vivo.
However, I still prefer trying NETs/extracellular chromatin/histone removal from the blood using these emerging extracorporeal blood purification treatments for patients at high-risk of refractory SIRS and development of life-threatening sepsis/DIC.
Based on the largely failed clinical performance of systemically administered Activated Protein C, I have long believed the depletion of circulating charged histones and other extracellular chromatin debris that aggregates cells, rather than drug neutralization of histones, provides the greatest opportunity for restoring immune system homeostasis and improving blood hemostasis in response to infection and other triggers of worsening NETosis dysregulation.”
Ronald Li, Associate Professor in Emergency and Critical Care at North Carolina State University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers in Veterinary Science:
“Congratulations Dr. Maria Andrea Guzman Solano on this publication.
As a member of the graduating class of the Veterinary Academic Leadership Fellow program at NC State College of Veterinary Medicine, she successfully advanced her research idea from conception through execution to publication.
I am excited to see her continue this research path as she takes on a new role as Associate Professor of Emergency and Critical Care at the University of Missouri.”
Title: Non-anticoagulant heparin attenuates histone-mediated platelet–leukocyte aggregation and neutrophil extracellular trap formation in a canine whole blood model
Authors: Maria A. Guzmán, Lunden Simpson, Ronald H. L. Li
Other posts featuring Jim Hoffman on Hemostasis Today.
-
Apr 21, 2026, 09:00Amer Zeidan: Can Early Blood Count Changes Predict Imetelstat Response in Lower Risk MDS?
-
Apr 21, 2026, 08:49Giacomo Buso: Global Collaboration in Vascular Medicine at the XI ESVM Congress 2026
-
Apr 21, 2026, 08:26Rehan Raina: Did You Know Your Immune Cells are What Actually Kill Cancer?
-
Apr 20, 2026, 18:59Chokri Ben Lamine: Contributing to a Landmark Chapter on Amegakaryocytic Thrombocytopenia in Bone Marrow Failure
-
Apr 20, 2026, 18:39David McIntosh: A Watershed Moment for Global Plasma Community and Call for Unified Action
-
Apr 20, 2026, 18:15Nandini Pethe: Grateful for a Fantastic 2026 HFA Symposium Filled with Impactful Educational Sessions and Meaningful Connections
-
Apr 20, 2026, 17:13Armghan Ans: The Stroke Decision Nobody Owns
-
Apr 20, 2026, 17:12Assefa Desalew: RhD-Negative Status and Adverse Perinatal Outcomes in Eastern Ethiopia
-
Apr 20, 2026, 16:55Francesco Lo Monaco: Blood Type and Heart Risk – Small Differences, Bigger Role of Lifestyle